Elpetrigine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameElpetrigine
Drug Alias Nameelpetrigina依培曲近elpetriginum艾培三嗪GW-293273 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersSodium channel protein type II alpha subunit blockers
TargetsSodium channel protein type II alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsBipolar DisorderEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcJazz Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsBipolar DisorderEpilepsy

Other Information

ATC CodeN/A
Related LinksKEGG